The effect of institutional experience on overall survival ( OS ) in patients with stage III or IV HNC was investigated within a randomized trial of the Radiation Therapy Oncology Group ( RTOG 0129 ) , which compared cisplatin concurrent with standard versus accelerated fractionation radiotherapy .